Rock Health Summit Happy Hour Hosted by Illumina Accelerator & Xcell Biosci...

Event Information

Share this event

Date and Time

Location

Location

455 Mission Bay Blvd

San Francisco, CA 94158

View Map

Event description

Description

Join Illumina Accelerator and Xcell Bio to discuss the intersection of digital health and genomics! Stop by and meet Illumina Accelerator startups, entrepreneurs, and investors that are pushing the boundaries in genomics and data science.

Agenda:

6:00 PM - Conference Guests walk over from Rock Health UCSF Convention Center (escorted by Marc Casas of Illumina Accelerator)

6:15 PM - Networking

6:45 PM - Brief Panel about Entrepreneurship in Genomics & Digital Health

  • Moderator: Amanda Cashin, Global Head, Illumina Accelerator
  • Panelists: BioAmp Diagnostics' Co-founder & CEO Hana Janebdar, Juno Bio Limited's Co-founder & CEO Simon Kennedy, TriAxia Health's Co-founder & CEO Simon Kennedy, and XCell Bio's Co-founder & CEO Brian Feth

7:15 PM – Networking

8:15 PM - Departure


About Illumina Accelerator

At Illumina, we’re committed to unlocking the power of the genome, and we know we can’t do it alone. Illumina Accelerator is our way of accelerating innovation in the entrepreneurial community. With extensive mentorship, financial support, and access to sequencing systems, reagents, and lab space, we are building a dynamic ecosystem to help genomics startups launch in the San Francisco Bay Area. Together, we'll advance breakthrough applications in genomics, including therapeutics, diagnostics, agriculture, synthetic biology, forensics, and direct-to-consumer applications.


About Xcell Bio

Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Our proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies. This unique and powerful capability results from tuning with precise control, a range of conditions found within the human microenvironment. Changes in the exogenous cellular environment enables direct disease insights for drug development, including phenotypic and functional changes that may occur in a bone marrow, vasculature, or an immunosuppressive tumor microenvironment. It also enables directed enrichment, expansion, and functional control of important target and therapeutic cell types of interest.

Date and Time

Location

455 Mission Bay Blvd

San Francisco, CA 94158

View Map

Save This Event

Event Saved